Sex, BMI, smoking, serum lipids, HbA1c, CKD, history of previous CHD and mild valvular heart disease, and use of ACE-inhibitors, angiotensin receptor antagonists, beta blockers, lipid-lowering, anti-platelet and hypoglycemic drugs did not significantly differ between the groups. This evidence concerns the gene ACE and heart valve disorder.